Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Applied Therapeuticsappliedtherapeutics.com · Low evidenceApplied Therapeutics is a biopharmaceutical company developing govorestat, an investigational therapy for rare diseases including Classical Galactosemia and CMT-SORD. The company has discontinued its sponsored clinical studies of govorestat to evaluate new development strategies after the FDA issued a Complete Response Letter for the drug in November 2024.
Parse Score